Novo Holdings to make changes to its Board of Directors
Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step down as Chair.
Lars Green has more than 30 years of leadership experience in the healthcare and life science industries.
He joined Novo Nordisk in 1992 and has held various financial leadership positions in the company, including regional CFO roles in Japan and North America, before joining Executive Management in 2017. In 2019, Lars Green joined Novozymes (Novonesis) where he served as CFO until the end of 2023.
